Higher Fluids in the First Th ree Hours of Sepsis Resuscitation? Too Soon to Conclude
To the Editor:
It is with great interest that we read the retrospective study published by Lee et al 1 in a recent issue of CHEST ( October 2014) that showed a signifi cant decrease in hospital mortality in patients who received early fl uid resuscitation within the fi rst 3 h of onset of severe sepsis or septic shock. However, some important points related to this study need to be addressed.
Th e authors used electronic medical records (EMRs) to identify patients with severe sepsis and septic shock. "Sepsis onset time" was determined by fl uidresistant hypotension, vasopressor use, or a lactate level . 4 mmol/L. 1 Th e reliability and validity of the outcome data in EMR-based interventional studies depend on the accuracy of data collection, entry, and storage. A study conducted on the Veterans Administration's EMRs, a highly integrated and standardized EMR system, showed that 60% of the patients had one or more input-related errors, with an average of 7.8 errors per patient. 2 Th e use of EMRs in observational studies is subject to selection bias and confounding. 3 In the study by Lee et al, 1 nonsurvivors were signifi cantly older, had a higher severity of illness, and more organ dysfunction. Nonsurvivors also had lower net-positive fluid balance in the fi rst 3 h of resuscitation. Th e authors suggested the unavailability of a central venous catheter as a possible explanation for underachieved resuscitation goals. However, the presence of certain medical conditions, such as congestive heart failure or chronic kidney disease, can also limit liberal fl uid use. Patients with congestive heart failure and chronic kidney disease were not excluded in the study by Lee et al. 1 Physicians may also limit aggressive care when presence of advanced medical illness or prior advance directives precludes this approach, thereby introducing treatment bias. In the recently published Protocolized Care for Early Septic Shock (ProCESS) trial, there were no outcome diff erences among the study groups despite receiving signifi cantly diff erent fl uid volumes. 4 In this randomized trial, patients with acute pulmonary edema, do-not-resuscitate status, or those deemed unsuitable for aggressive care were excluded. 4 In a retrospective observational study, treatment selection bias can infl uence both the choice for a particular treatment and the outcome of interest. Th e confounding introduced by this type of bias cannot be adjusted with traditional logistic regression analyses. 5 Adequate adjustment for treatment selection and confounding bias requires inclusion of variables that may be unknown or unavailable in a retrospective cohort. As appropriately indicated by Lee et al, 1 their results need to be validated with a prospective study. We thank Drs Adrish and Soto for their comments on our recent article in CHEST . 1 We agree that electronic medical records, especially progress notes, are subject to human entry error. However, the data in the study were gathered in near real-time entry into the ICU Datamart database as hemodynamics were monitored and fl uids were given by providers. 2 , 3 Vital signs, laboratory fi ndings, and medication administration are automatically captured and also validated by ICU nurses at hourly intervals. Th e study period was selected for completeness and accuracy of the data, which took several years to collect, recheck, and validate against any errors.
We agree that retrospective studies have limitations compared with prospective randomized controlled trials. Th e weaknesses of the observational study design have been outlined in the discussion of our article. 1 It is possible that fl uid was conservatively given to some patients per the individual clinician's decision-making. However, it is unlikely that fl uid was systematically withheld to a group of patients with select chronic conditions as that would be inconsistent with the institution's sepsis resuscitation protocol. Furthermore, we incorporated into the logistic regression analysis age and APACHE (Acute Physiology and Chronic Health Evaluation) and Sequential Organ Failure Assessment (SOFA) scores to account for chronic medical conditions and severity of acute illness. Nevertheless, we cannot exclude potential bias resulting from unmeasured confounders.
In regard to the Protocolized Care for Early Septic Shock (ProCESS) trial, enrollment into the study occurred within (or up to) 2 h of sepsis recognition and within (or up to) 12 h aft er ED admission. By the time of enrollment into the study, patients had already received 2.2 L or about 29 mL/kg (30.5 Ϯ 22.3 in early goaldirected therapy, 29.2 Ϯ 19.1 in protocol, and 28 Ϯ 21 in usual care group). 4 Given that all three groups initially received similar amounts of fl uids early in their resuscitation (prior to randomization), ProCESS trial results do not necessarily seem to refute our fi ndings.
